The Impact of Maintaining Normal Serum Albumin Level Following Living Related Liver Transplantation: Does Serum Albumin Level Affect the Course? A Pilot Study

Transplantation Proceedings

Volumn 39, Issue 10, 2007, Pages 3214-3218

  Mukhtar, A ^a   EL Masry, A ^a   Moniem, A A ^a   Metini, M ^a   Fayez, A ^a   Khater, Y H ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HUMAN ALBUMIN; PROTHROMBIN; TACROLIMUS;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD PRESSURE; BLOOD TRANSFUSION; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE COURSE; FEMALE; FLUID THERAPY; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HUMAN; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; LIVER TRANSPLANTATION; LIVING DONOR; MALE; PILOT STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTHROMBIN TIME; TREATMENT OUTCOME;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BIOLOGICAL MARKERS; CREATININE; FEMALE; HUMANS; LENGTH OF STAY; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PILOT PROJECTS; REFERENCE VALUES; SERUM ALBUMIN; TREATMENT OUTCOME;

EID: 37049019036     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.06.084     Document Type: Article

References (15)

1. Guyton A.C., Granger H.J., and Taylor A.E. Interstitial fluid pressure. Physiol Rev 51 (1971) 527
2. Marx G., Vangerow B., Burczyk C., et al. Evaluation of noninvasive determinants for capillary leakage syndrome in septic shock patients. Intensive Care Med 26 (2000) 1252
3. Emerson Jr. T.E. Unique features of albumin: a brief review. Crit Care Med 17 (1989) 690
4. Engelman D.T., Adams D.H., Byrne J.G., et al. Impact of body mass index and albumin on morbidity and mortality after cardiac surgery. J Thorac Cardiovasc Surg 118 (1999) 866
5. Gibbs J., Cull W., Henderson W., et al. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg 134 (1999) 36
6. Cohen J., Shapiro M., Grozovski E., et al. Should hypoalbuminemia after liver transplantation be corrected?. Transplant Proc 33 (2001) 2916
7. Grootendorst A.F., van Wilgenburg M.G., de Laat P.H., et al. Albumin abuse in intensive care medicine. Intensive Care Med 14 (1988) 554
8. Dubois M.J., Orellana-Jimenez C., Melot C., et al. Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med 34 (2006) 2536
9. Warty V., Venkataramanan R., Zendehrouh P., et al. Distribution of FK 506 in plasma lipoproteins in transplant patients. Transplant Proc 23 (1991) 954
10. Trull A., Hughes V., Cooper D., et al. Influence of albumin supplementation on tacrolimus and cyclosporine therapy early after liver transplantation. Liver Transpl 8 (2002) 224
11. Papadakis M.A., and Arieff A.I. Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study. Am J Med 82 (1987) 945
12. Wiesner R., Rabkin J., Klintmalm G., et al. A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients. Liver Transpl 7 (2001) 442
13. Fischer L., Sterneck M., Gahlemann C.G., et al. A prospective study comparing safety and efficacy of mycophenolate mofetil versus azathioprine in primary liver transplant recipients. Transplant Proc 32 (2000) 2125
14. Jassem W., Koo D.D., Cerundolo L., et al. Cadaveric versus living-donor livers: differences in inflammatory markers after transplantation. Transplantation 76 (2003) 1599
15. Murray M.J., Marsh H.M., Wochos D.N., et al. Nutritional assessment of intensive-care unit patients. Mayo Clin Proc 63 (1988) 1106